Exchange: NASDAQ·Updated 05:23 AM EDT
BCRX logo

BCRXBiocryst Pharmaceuticals Inc.

$9.59
$0.06
(0.63%)
Pre-Market
Prev Close $9.53
EarningsAug 5
Mkt Cap$2.48B
Vol16,074.00
News
all
press releases
Missed AI, Memory Bull Run? Biotech May Be The Next Breakout Trade — But Retail Sentiment Has Never Been Lower
Drugmakers have announced 37 biotech acquisitions worth at least $1 billion this year, topping the previous annual record.
Stocktwits
More News
BioCryst Pharmaceuticals Appoints David Jenkins As Chief Scientific Officer
(RTTNews) - BioCryst Pharmaceuticals, Inc. (BCRX) said on Wednesday that it has appointed David W. Jenkins to the newly created role of Chief Scientific Officer with immediate effect...
Nasdaq News: Markets
Wall Street Analysts Think BioCryst (BCRX) Could Surge 117.96%: Read This Before Placing a Bet
The consensus price target hints at an 118% upside potential for BioCryst (BCRX). While empirical research shows that this sought-after metric is hardly effective, an upward trend in earnings estimate revisions could mean that the stock will witness an upside in the near term.
Zacks
Why Did PENG, ANET, BCRX Shares Surge To 52-Week Highs?
Penguin Solutions, Arista Networks, and Biocryst Pharmaceuticals surged to 52-week highs on Wednesday amid a rotation into technology and healthcare stocks.
Stocktwits
BioCryst (BCRX) Surges 8.1%: Is This an Indication of Further Gains?
BioCryst (BCRX) was a big mover last session on higher-than-average trading volume. The latest trend in earnings estimate revisions might help the stock continue moving higher in the near term.
Zacks
VKTX Vs BCRX: Which Biotech Takeover Favorite Offers More Upside After Vertex’s $10B CRNX Deal?
Wall Street sees bigger upside in VKTX, with Koyfin’s average target implying 120% upside versus 99% for BCRX.
Stocktwits
Why Did CRNX, D, BCRX Stocks Surge To 52-Week Highs Today?
Investors favored companies benefiting from biotech deals, rising power demand from AI data centers, and cost-cutting efforts to improve profits.
Stocktwits
Ono Pharmaceutical Co. (OPHLF) Moves 10.4% Higher: Will This Strength Last?
Ono Pharmaceutical Co. (OPHLF) witnessed a jump in share price last session on above-average trading volume. The latest trend in earnings estimate revisions for the stock doesn't suggest further strength down the road.
Zacks
BCRX Stock Set For Best Week In Over 3 Months – Retail Shifts Focus To This Crucial Breakout Level
BCRX stock climbed past its key resistance at $10.32 to hit a record high earlier in the session, before paring most of the gains.
Stocktwits
These Analysts Revise Their Forecasts On BioCryst Pharma After Q1 Earnings
BioCryst Pharma (NASDAQ:BCRX) reported strong Q1 earnings, reaffirmed FY2026 sales guidance, and received positive price target changes from analysts.read more...
Benzinga
<
1
2
>

Advertisement|Remove ads.